Amanta Healthcare IPO

Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices. The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment. The company markets products through three business units: National sales, International sales and Product partnering with various foreign and Indian pharmaceutical companies. The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists. The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries. As of March 31, 2025, the company has a team of 1,718 employees at its formulation and development and quality laboratory.   Competitive Strengths Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market. Large manufacturing capabilities Wide Domestic and International Marketing Network. Experienced management team supported by a large, diverse and skilled workforce.

Information on this page is for general awareness only and is not investment advice. Grey market premium (when shown) is unofficial and indicative. Always read the RHP/DRHP and consult a qualified adviser before investing.